Department of Health and Social Care
Molnupiravir (EIDD-2801/MK-4482) Supply Agreement for Pandemic Purposes
This is a contract result notice, not an open opportunity. Details from the official award data.
Vaccines have been shown to be highly effective in the fight against COVID-19, to date.
However, there is a cohort of individuals who either cannot take the vaccine or for whom it is ineffective.
There is therefore an urgent need to find an effective alternative.
So far there are no primary care antiviral drugs that can be easily dispensed specifically to treat SARS-CoV-2 and prevent its transmission in the community.
This agreement is for the procurement of 480,000 units of Molnupiravir (EIDD-2801/MK-4482).
It is one of the first oral and direct-acting antiviral drugs globally and the first to receive regulatory approval and is part of the UK’s multi-layered approach to COVID-19.
What the notice asks for
There is therefore an urgent need
There is therefore an urgent need to find an effective alternative.
Sentences from the notice that state an obligation, surfaced automatically and shown in the order they appear. Not an exhaustive list — always confirm against the tender documents.
Make the case to bid
Reveal who to approach at Department of Health and Social Care, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- ocds-h6vhtk-02f5dc
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 028271-2021
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
Department of Health and Social Care’s tender network